Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 3
2007 3
2008 1
2010 3
2011 3
2013 3
2014 2
2015 4
2016 1
2017 1
2018 2
2019 2
2020 2
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Identification of ALK as a major familial neuroblastoma predisposition gene.
Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM. Mossé YP, et al. Among authors: perri p. Nature. 2008 Oct 16;455(7215):930-5. doi: 10.1038/nature07261. Epub 2008 Aug 24. Nature. 2008. PMID: 18724359 Free PMC article.
Familial neuroblastoma: a complex heritable disease.
Tonini GP, Longo L, Coco S, Perri P. Tonini GP, et al. Among authors: perri p. Cancer Lett. 2003 Jul 18;197(1-2):41-5. doi: 10.1016/s0304-3835(03)00080-6. Cancer Lett. 2003. PMID: 12880958 Review.
Bone Marrow Environment in Metastatic Neuroblastoma.
Brignole C, Pastorino F, Perri P, Amoroso L, Bensa V, Calarco E, Ponzoni M, Corrias MV. Brignole C, et al. Among authors: perri p. Cancers (Basel). 2021 May 19;13(10):2467. doi: 10.3390/cancers13102467. Cancers (Basel). 2021. PMID: 34069335 Free PMC article. Review.
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models.
Di Paolo D, Pastorino F, Brignole C, Corrias MV, Emionite L, Cilli M, Tamma R, Priddy L, Amaro A, Ferrari D, Marotta R, Ferretti E, Pfeffer U, Ribatti D, Sementa AR, Brown D, Ikegaki N, Shimada H, Ponzoni M, Perri P. Di Paolo D, et al. Among authors: perri p. Small. 2020 May;16(20):e1906426. doi: 10.1002/smll.201906426. Epub 2020 Apr 22. Small. 2020. PMID: 32323486
The use of the orthotopic model to validate antivascular therapies for cancer.
Loi M, Di Paolo D, Becherini P, Zorzoli A, Perri P, Carosio R, Cilli M, Ribatti D, Brignole C, Pagnan G, Ponzoni M, Pastorino F. Loi M, et al. Among authors: perri p. Int J Dev Biol. 2011;55(4-5):547-55. doi: 10.1387/ijdb.103230ml. Int J Dev Biol. 2011. PMID: 21858775 Free article. Review.
Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.
Ponzoni M, Curnis F, Brignole C, Bruno S, Guarnieri D, Sitia L, Marotta R, Sacchi A, Bauckneht M, Buschiazzo A, Rossi A, Di Paolo D, Perri P, Gori A, Sementa AR, Emionite L, Cilli M, Tamma R, Ribatti D, Pompa PP, Marini C, Sambuceti G, Corti A, Pastorino F. Ponzoni M, et al. Among authors: perri p. Small. 2018 Nov;14(45):e1802886. doi: 10.1002/smll.201802886. Epub 2018 Oct 7. Small. 2018. PMID: 30294852
Oligogenic inheritance in neuroblastoma.
Longo L, Tonini GP, Ceccherini I, Perri P. Longo L, et al. Among authors: perri p. Cancer Lett. 2005 Oct 18;228(1-2):65-9. doi: 10.1016/j.canlet.2004.12.052. Cancer Lett. 2005. PMID: 15923081
41 results